Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Effect of deuteration on the metabolism and clearance of some pharmacologically active compounds--synthesis and in vitro metabolism of deuterated derivatives of dronedadrone.

Schofield J, Brasseur D, de Bruin B, Vassal T, Klieber S, Arabeyre C, Bourrié M, Sadoun F, Fabre G.

J Labelled Comp Radiopharm. 2013 Jul-Aug;56(9-10):504-12. doi: 10.1002/jlcr.3090. Epub 2013 Sep 4.

PMID:
24285529
2.

Contribution of the N-glucuronidation pathway to the overall in vitro metabolic clearance of midazolam in humans.

Klieber S, Hugla S, Ngo R, Arabeyre-Fabre C, Meunier V, Sadoun F, Fedeli O, Rival M, Bourrie M, Guillou F, Maurel P, Fabre G.

Drug Metab Dispos. 2008 May;36(5):851-62. doi: 10.1124/dmd.107.019539. Epub 2008 Feb 6.

PMID:
18256203
3.

In vitro metabolism of ferroquine (SSR97193) in animal and human hepatic models and antimalarial activity of major metabolites on Plasmodium falciparum.

Daher W, Pelinski L, Klieber S, Sadoun F, Meunier V, Bourrié M, Biot C, Guillou F, Fabre G, Brocard J, Fraisse L, Maffrand JP, Khalife J, Dive D.

Drug Metab Dispos. 2006 Apr;34(4):667-82. Epub 2006 Jan 13.

PMID:
16415117
4.

Expression and induction of CYP1A1/1A2, CYP2A6 and CYP3A4 in primary cultures of human hepatocytes: a 10-year follow-up.

Meunier V, Bourrié M, Julian B, Marti E, Guillou F, Berger Y, Fabre G.

Xenobiotica. 2000 Jun;30(6):589-607.

PMID:
10923861
5.

Role of cytochrome P-4502C9 in irbesartan oxidation by human liver microsomes.

Bourrié M, Meunier V, Berger Y, Fabre G.

Drug Metab Dispos. 1999 Feb;27(2):288-96.

PMID:
9929518
6.

Correlation between oral drug absorption in humans, and apparent drug permeability in TC-7 cells, a human epithelial intestinal cell line: comparison with the parental Caco-2 cell line.

Grès MC, Julian B, Bourrié M, Meunier V, Roques C, Berger M, Boulenc X, Berger Y, Fabre G.

Pharm Res. 1998 May;15(5):726-33.

PMID:
9619781
7.

Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalyzed by human liver microsomes.

Bourrié M, Meunier V, Berger Y, Fabre G.

J Pharmacol Exp Ther. 1996 Apr;277(1):321-32.

PMID:
8613937
8.

The human intestinal epithelial cell line Caco-2; pharmacological and pharmacokinetic applications.

Meunier V, Bourrié M, Berger Y, Fabre G.

Cell Biol Toxicol. 1995 Aug;11(3-4):187-94. Review.

PMID:
8564649
9.

In vitro N-glucuronidation of SB 47436 (BMS 186295), a new AT1 nonpeptide angiotensin II receptor antagonist, by rat, monkey and human hepatic microsomal fractions.

Perrier L, Bourrié M, Marti E, Tronquet C, Massé D, Berger Y, Magdalou J, Fabre G.

J Pharmacol Exp Ther. 1994 Oct;271(1):91-9.

PMID:
7965761
10.

Regulation of cytochrome P450IA1 gene expression in a human intestinal cell line, Caco-2.

Boulenc X, Bourrie M, Fabre I, Roque C, Joyeux H, Berger Y, Fabre G.

J Pharmacol Exp Ther. 1992 Dec;263(3):1471-8.

PMID:
1469646
11.

Delta 2-valproate biotransformation using human liver microsomal fractions.

Fabre G, Briot C, Marti E, Montseny JP, Bourrié M, Massé D, Berger Y, Cano JP.

Pharm Weekbl Sci. 1992 Jun 19;14(3A):146-51.

PMID:
1502016
12.

Involvement of the cytochrome P-450IID subfamily in minaprine 4-hydroxylation by human hepatic microsomes.

Marre F, Fabre G, Lacarelle B, Bourrie M, Catalin J, Berger Y, Rahmani R, Cano JP.

Drug Metab Dispos. 1992 Mar-Apr;20(2):316-21.

PMID:
1352227

Supplemental Content

Loading ...
Support Center